Filing Details
- Accession Number:
- 0000874716-24-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-07 17:00:38
- Reporting Period:
- 2024-03-06
- Accepted Time:
- 2024-03-07 17:00:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1389046 | F James Polewaczyk | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-06 | 755 | $206.94 | 11,466 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-06 | 483 | $206.94 | 11,949 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-06 | 2,226 | $288.78 | 14,175 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-06 | 4,640 | $544.08 | 18,815 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-06 | 4,134 | $557.94 | 14,681 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-06 | 3,290 | $558.88 | 11,391 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-06 | 680 | $559.33 | 10,711 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2024-03-06 | 755 | $0.00 | 755 | $206.94 |
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2024-03-06 | 483 | $0.00 | 483 | $206.94 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2024-03-06 | 2,226 | $0.00 | 2,226 | $288.78 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2024-03-06 | 4,640 | $0.00 | 4,640 | $544.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-02-13 | No | 4 | M | Direct | |
| 0 | 2029-02-13 | No | 4 | M | Direct | |
| 0 | 2030-02-13 | No | 4 | M | Direct | |
| 1,363 | 2031-02-13 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average price of the shares sold ranging from a low of $557.33 to a high of $558.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $558.45 to a high of $559.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $559.51 to a high of $559.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
- Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024.
- Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
- Grant of option to buy 6,003 shares of Issuer common stock that vest in four annual installments beginning February 14, 2022.
Billionaire Hedge Funds
